Took 1/2 position expecting pullback to buy remainder on dip. Acquired a like-company in imaging diagnostics. Playing short term. Acquisition was stated as IMMEDIATELY ACCRETIVE, paid in CASH. Strong comments from CEO and CFO regarding double revenue growth ($64M end of year to $125M next year, EBITDA of $17M). Upside of $5.5+. very conservative price would be based on a 10 P/E which would be $7.5. Long term estimated EPS around 0.41 with a conservative P/E would be a stock target around $12